⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2903405 | 0.89 | — | — | |
| SCHEMBL2903026 | 0.87 | — | — | |
| SCHEMBL2904858 | 0.87 | — | — | |
| SCHEMBL2903441 | 0.87 | — | — | |
| SCHEMBL2903264 | 0.86 | — | — | |
| SCHEMBL1058523 | 0.84 | — | — | |
| SCHEMBL2902179 | 0.83 | — | — | |
| SCHEMBL2903147 | 0.82 | — | — | |
| SCHEMBL2897768 | 0.78 | — | — | |
| SCHEMBL2905021 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1982704-B1 | New molecular target of neurotoxicity | EXONHIT THERAPEUTICS SA (FR) | 2010-08-04 | — | — | EP | claimed |